Forward Citations = 6

Loading Chart...

8 inventors (with patents filed for the assignee):

Kevin M Friedman (5 out of 5 patents)

Molly R Perkins (5 out of 5 patents)

Andrew Avery (4 out of 7 patents)

4. Stephen L Sazinsky (4 out of 6 patents)

5. Cory Ahonen (4 out of 5 patents)

6. Emily Thompson Beura (4 out of 4 patents)

7. Connor S Dobson (4 out of 4 patents)

8. Shannon G Contrastano (4 out of 4 patents)

5 patents: Sort by Forward Citations

1. 12440564 - Compositions for treating cancer (2025-10-14),

2. 12435140 - Antigen binding polypeptides (2025-10-07),

3. 12403194 - Compositions for treating cancer (2025-09-02),

4. 12312593 - Lymphocyte targeted lentiviral vectors (2025-05-27),

5. 12269882 - Antigen binding polypeptides (2025-04-08),

Company Overview

Kelonia Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for patients with serious diseases. The company specializes in gene therapy and aims to address unmet medical needs through its proprietary platform. Kelonia's research is centered on harnessing the power of the immune system to create effective treatments for various conditions, including genetic disorders and cancers. With a commitment to advancing science and improving patient outcomes, Kelonia Therapeutics is at the forefront of therapeutic innovation.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#299 in Boston, MA

#2,894 in Massachusetts

#51,620 in US

Boston, MA, United States of America

Kelonia Therapeutics, Inc.

Forward Citations = 6

8 inventors:

Kevin M Friedman (5 out of 5 patents)

Molly R Perkins (5 out of 5 patents)

Andrew Avery (4 out of 7 patents)

4. Stephen L Sazinsky (4 out of 6 patents)

5. Cory Ahonen (4 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kelonia Therapeutics, Inc.. Retrieved from https://idiyas.com/company/kelonia-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]